Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study

Abstract

Clinical, open-label, observation, cohort study for assessment of efficacy and safety of biological drug abatacept in nonselective populations of several European countries and Canada. It is interim analysis of 2 years study

Keywords

• Abatacept
• biologic therapy
• observational study